4D Molecular Therapeutics
Powering the Future of Genetic Medicines
209 employees · est. 2013 · Emeryville, United States
Kinarus Therapeutics
Kinarus Therapeutics is a clinical-stage company developing therapies for viral, respiratory and ocular diseases.
5 employees · est. 2017 · Basel, Switzerland
4D Molecular Therapeutics is the older company (2013 vs 2017); 4D Molecular Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | 4D Molecular Therapeutics | Kinarus Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2013 older | 2017 |
| Headquarters | ||
| Headquarters | Emeryville, United States | Basel, Switzerland |
| Employees | ||
| Employees | 209 larger | 5 |
| Industry | ||
| Industry | Biotechnology | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $595.00M | $36.55M |
| Funding Rounds | ||
| Funding Rounds | 6 | 6 |
| Services | ||
| Services | Development of genetic medicines, Innovative vector platform, Clinical trial execution, Partnerships with patient organizations | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with retinal diseases, Patients with pulmonary diseases, Healthcare providers, Research organizations | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Genetic Medicines, Gene Therapy, Adeno-Associated Virus, Retinal Vascular Diseases, Ophthalmology, Wet Age-Related Macular Degeneration, Diabetic Macular Edema, Cystic Fibrosis, Clinical Trials, Medical Innovation, Therapeutic Products, Anti-VEGF Therapy, Transgene Delivery, Intravitreal Injection | Clinical-stage Pharmaceutical Company, Drug Development, Viral Diseases, Respiratory Diseases, Ophthalmic Diseases, P38 MAPK Inhibitor, Covid-19 Treatment, Phase 2 Clinical Trial, Age-Related Macular Degeneration, VEGF Inhibitors, Regulatory Approval, Patient-focused Treatments, Switzerland-based Company, Roche Collaboration, Hospitalized Patients |
| Website | ||
| Website | 4dmoleculartherapeutics.com | kinarus.com |
About 4D Molecular Therapeutics
4D Molecular Therapeutics, founded in 2013, is a leading late-stage biotechnology company headquartered in the United States. The company is on the forefront of advancing genetic medicines, aiming to revolutionize treatment paradigms with its cutting-edge therapeutics. Their slogan, "Powering the Fu...
About Kinarus Therapeutics
Kinarus Therapeutics is a clinical-stage pharmaceutical company based in Switzerland. Established in 2017, the company is dedicated to developing innovative treatments for viral, respiratory, and ophthalmic diseases. Their flagship drug candidate is an oral combination of a P38 mitogen-activated pro...
We will tell you when either one moves
BounceWatch watches 4D Molecular Therapeutics and Kinarus Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at 4D Molecular Therapeut... and Kinarus Therapeutics — by email.
Frequently Asked Questions
Compare 4D Molecular Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at 4D Molecular Therapeutics on 15 Jun 2026, and Kinarus Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
